INVO Bioscience’s Reverse Merger with NAYA Biosciences

Glaser Weil represented INVO Bioscience, Inc. on the merger agreement with NAYA Biosciences Inc., assisted by Pearl Cohen. INVO Bioscience, Inc. (Nasdaq: INVO), a global leader…

This content is for Standard 1 Year members only.
Login Join Now

Novartis’ Licensing Agreement with Arvinas

Uber Technologies $1.25bn Investment in Delivery Hero

Cooper Equipment Rentals’ Acquisition of Action Equipment Rentals

Raghsa’s US$10 Million Notes Issuance

San Miguel’s Public Offering

Cresud’s US$10 Million Notes Offering

IMA – Industria Macchine Automatiche’s €450 Million Additional High Yield Bonds Offering

Aikido’s $17 Million Series A Financing Round

Monese and XYB’s New Funding and Splitting

JS Virginia Proprietary Ltd’s Financing Of Renewable Project In South Africa

Injaro Investment Advisors’ Equity Investment in NME

Dislog Group’s Acquisition of CMB Plastique Maroc

OSN’s Acquisition of a Control Stake in Anghami

McLaren’s Successful Reorganisation with Mumtalakat

Skyports Infrastructure’s Dubai Launch

Marketingforce Management’s IPO on the Hong Kong Stock Exchange

Salmon’s $25 Million Series A-1 Financing

Hyundai Card’s $500 Million Notes Issuance

Katten Taps James Bookhout to Lead M&A Litigation in Dallas

Hinshaw Expands Health Care Practice on East Coast

BCLP Makes New Leadership Appointments

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

The Italian Revenue Agency Qualifies Directors’ Reversible Remuneration For The Purposes Of Double Taxation Agrements.

Katten Taps James Bookhout to Lead M&A Litigation in Dallas

Hinshaw Expands Health Care Practice on East Coast

Intellectual Property Partner Jeff Morton Joins Haynes Boone in Southern California

INVO Bioscience’s Reverse Merger with NAYA Biosciences

Author: Sonia Carcano